Insider trades
Lyons Gary A
Lyons Gary A made 0 buys and 10 sales on the open market in the last 12 months at Neurocrine Biosciences, Inc. and Travere Therapeutics, Inc. Each trade with the role, price and filing.
| Date | Company | Trade | Shares | Price |
|---|---|---|---|---|
| Nov 17, 2026 | Neurocrine Biosciences, Inc. | Sale | 1,200 | US$163.11 |
| Nov 17, 2026 | Neurocrine Biosciences, Inc. | Sale | 4,011 | US$163.94 |
| Nov 17, 2026 | Neurocrine Biosciences, Inc. | Sale | 5,689 | US$165.15 |
| Nov 17, 2026 | Neurocrine Biosciences, Inc. | Sale | 4,100 | US$165.90 |
| Aug 18, 2026 | Travere Therapeutics, Inc. | Sale | 900 | US$63.86 |
| Aug 18, 2026 | Travere Therapeutics, Inc. | Sale | 4,100 | US$63.27 |
| Aug 17, 2026 | Travere Therapeutics, Inc. | Sale | 500 | US$64.16 |
| Aug 17, 2026 | Travere Therapeutics, Inc. | Sale | 1,900 | US$62.53 |
| Aug 17, 2026 | Travere Therapeutics, Inc. | Sale | 2,600 | US$63.50 |
| Apr 14, 2026 | Travere Therapeutics, Inc. | Sale | 8,000 | US$41.07 |